A new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) says that a molecule in cells that shuts down the expression of genes might be a promising target for new drugs designed to treat the most frequent and lethal form of brain cancer. The findings, published in the journal iCancer Research/i, show that high levels of the enzyme PRMT5 are ...
Read MoreYou have just read an article categorized health
titled Possible New Target for Future Brain Cancer Drugs Uncovered in Study.
Written by:
editor - Saturday, March 1, 2014
There are currently no comments for "Possible New Target for Future Brain Cancer Drugs Uncovered in Study"
Post a Comment